Ansgar Resch
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
Papers in
- Co-authors
- Michael BlankDaniela ProskeRaymund BuhmannMichael WilkeS DuttaguptaTheodor KlotzMartin BurkartBernd Brüggenjürgen
- Journals
- Value in Health (6 papers)Journal of Diabetes Science and Technology (2 papers)The European Journal of Health Economics (2 papers)Infection (1 paper)Applied Microbiology and Biotechnology (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Ansgar Resch
19 papers receiving 531 citations
Peers
Comparison fields: 5 of 85
- Applied Microbiology and Biotechnology 45
- Infectious Diseases 120
- Urology 38
- Molecular Medicine 28
- Clinical Biochemistry 38
Countries citing papers authored by Ansgar Resch
This map shows the geographic impact of Ansgar Resch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ansgar Resch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ansgar Resch more than expected).
Fields of papers citing papers by Ansgar Resch
This network shows the impact of papers produced by Ansgar Resch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ansgar Resch. The network helps show where Ansgar Resch may publish in the future.
Co-authors
The 25 scholars most cited alongside Ansgar Resch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 4 | |
| 2 | 2013 | 23 | |
| 3 | 2011 | 5 | |
| 4 | 2010 | 40 | |
| 5 | 2009 | 33 | |
| 6 | 2008 | 24 | |
| 7 | 2008 | 67 | |
| 8 | 2007 | 2 | |
| 9 | 2006 | 38 | |
| 10 | 2006 | 31 | |
| 11 | 2005 | 208 | |
| 12 | 2005 | 4 | |
| 13 | 2005 | 1 | |
| 14 | 2004 | 6 | |
| 15 | 2004 | 6 | |
| 16 | 2004 | 4 | |
| 17 | 2004 | 1 | |
| 18 | 1999 | 50 | |
| 19 | 1998 | 9 |
About Ansgar Resch
Ansgar Resch is a scholar working on Applied Microbiology and Biotechnology, Metals and Alloys, Critical Care and Intensive Care Medicine, Infectious Diseases and Endocrinology, Diabetes and Metabolism, having authored 19 papers that have together received 556 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (5 papers), Antifungal resistance and susceptibility (3 papers), Diabetes Management and Research (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Nosocomial Infections in ICU (2 papers), Diabetes and associated disorders (2 papers), Coronary Interventions and Diagnostics (2 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (45 citations), Infectious Diseases (120 citations), Urology (38 citations), Molecular Medicine (28 citations) and Clinical Biochemistry (38 citations). Ansgar Resch has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Michael Blank, Daniela Proske, Raymund Buhmann, Michael Wilke, S Duttagupta, Theodor Klotz, Martin Burkart, Bernd Brüggenjürgen, E De Cock and A. Stemberger. Their work appears in journals such as Value in Health, Journal of Diabetes Science and Technology, The European Journal of Health Economics, Infection and Applied Microbiology and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.